PCR-based assessment of the recovery rate of exfoliated colonocytes or cancer cells from fecal samples depends on the storage conditions after defecation

Journal of Gastrointestinal and Liver Diseases

Volumn 16, Issue 4, 2007, Pages 369-372

  Onouchi, Shigeki ^a   Matsushita, Hisayuki ^b   Nomura, Sayuri ^c   Minowa, Takashi ^c   Matsumura, Yasuhiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c HITACHI LTD   (Japan)

Author keywords

Colonocytes; Colorectal cancer; DNA analysis; Fecal storage conditions; Mass screening

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; COLORECTAL CANCER; DEFECATION; GENE AMPLIFICATION; GENETIC ANALYSIS; HUMAN; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; STORAGE;

ADENOMATOUS POLYPOSIS COLI PROTEIN; COLORECTAL NEOPLASMS; DEFECATION; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; ENTEROCYTES; FECES; GENES, P53; GENES, RAS; HUMANS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 37549028040     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. The Editional Board of the Cancer Statistics in Japan. CANCER STATISTICS IN JAPAN-2005. http://www.fpcr.or.jp.
2. Bosman FT. Prognostic value of pathological characteristics of colorectal cancer. Eur J Cancer 1995;31:1216-21.
3. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 1998; 317(7158): 559-65.
4. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale. Update based on new evidence. Gastroenterology 2003; 124:544-560.
5. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-1607.
6. Lieberman DA, Weiss DG; Veterans Affairs Cooperative Study Group 380. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001;345:555-560.
7. Sung JJ, Chan FK, Leung WK, et al. Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy. Gastroenterology 2003;124:608-614.
8. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Colorectal Cancer Study Group. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-2714.
9. Sidransky D, Tokino T, Hamilton SR, et al. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992;256:102-105.
10. Hasegawa Y, Takeda S, Ichii S, et al. Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA). Oncogene 1995;10:1441-1445.
11. Smith-Ravin J, England J, Talbot IC, Bodmer W. Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. Gut 1995;36:81-86.
12. Eguchi S, Kohara N, Komuta K, et al. Mutations of the p53 gene in the stool of patients with resectable colorectal cancer. Cancer 1996;77(8 Suppl):1707-710.
13. Nollau P, Moser C, Weinland G, et al. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. Int J Cancer 1996;66:332-336.
14. Ratto C, Flamini G, Sofo L, et al. Detection of oncogene mutation from neoplastic colonic cells exfoliated in feces. Dis Colon Rectum 1996;39:1238-1244.
15. Deuter R, Muller O. Detection of APC mutations in stool DNA of patients with colorectal cancer by HD-PCR. Hum Mutat 1998;11:84-89.
16. Ahlquist DA, Skoletsky JE, Boynton KA, et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000;119:1219-1227.
17. Dong SM, Traverso G, Johnson C, et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst 2001;93:858-865.
18. Rengucci C, Maiolo P, Saragoni L, et al. Multiple detection of genetic alterations in tumors and stool. Clin Cancer Res 2001;7:590-593.
19. Yamao T, Matsumura Y, Shimada Y, et al. Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer. Gastroenterology 1998;114: 1196-1205.
20. Ahmed FE, James SL, Lysle DT, et al. Improved methods for extracting RNA from exfoliated human colonocytes in stool and RT-PCR analysis. Digest Dis Sci 2004; 49: 1889-1898.
21. Matsushita H, Matsumura Y, Moriya Y, et al. A new method for isolating colonocytes from naturally evacuated feces and its clinical application to colorectal cancer diagnosis. Gastroenterology 2005;129:1918-1927.